Skip to main content


Serious Infection Risk High in Patients With Lupus

MedPage Today

Patients with systemic lupus erythematosus (SLE) had two to four times higher risk for serious infection requiring hospitalization, a nationwide Swedish study found.

RheumNow Podcast – Do More DMARDs Mean More Switching? (9.17.2021)

Smartphones and diet; COVID-19 and the numbers - reassuring or not, and what about masks?; and do more drugs mean more switching, less persistence, and patient adherence goes up...or down? All this and more news and journal reports in this week's episode.

ACR Responds to 2022 Medicare Physician Fee Schedule Proposed Rule


In comments submitted to the Centers for Medicare and Medicaid Services (CMS), the American College of Rheumatology (ACR) shared its perspective on the CY 2022 Medicare Physician Fee Schedule and Quality Payment Program proposed rule. 

Canakinumab Use in Periodic Febrile Disorders

A retrospective records review of patients with periodic fever syndromes (PFS)  receiving IL-1 inhibitor treatment with canakinumab (CAN), shows CAN to be effective and safe in a variety of PFS patients.

Effect of Diet on COVID Outcomes

A smartphone-based symptom study of COVID-19 patients has shown that a healthy plant-based diet was associated with lower risk and severity of COVID-19, especially amongst those living in areas with higher socioeconomic deprivation.

Different Regimens but Equal Outcomes in Polyarticular JIA

CARRA (Childhood Arthritis and Rheumatology Research Alliance) has compared 3 different treatment strategies for polyarticular JIA to identify the optimal time to biologic regimen.

Pneumocystis Often Lethal in Dermatomyositis

MedPage Today

Patients with dermatomyositis who were positive for a myositis-specific antibody had a much higher incidence of and mortality associated with Pneumocystis jirovecii infection than patients with other antibody-negative idiopathic inflammatory myopathies, Chinese researchers found.

High Drug Switching and Low Persistence in Rheumatoid Arthritis

Mease and colleagues have catalogued the current practices assessed in the CORRONA registry, noting that increased DMARD switching and decreased time on a given therapy by US physicians.

ACR Comments on JAK Inhibitors and FDA Announcement

Following is a statement from ACR President David Karp, MD, PhD, on JAK inhibitors and FDA drug safety communication.

RheumNow Podcast – High Science and Future Treatments (9.10.2021)

This week: high science that affect future treatments; breakthrough infections in our patients, and what's up with that; and soon your radiologist is going to be replaced by AI. This and more in our review of the news and journal articles from the past week.

FDA Review of Vaping Products Extended

The FDA has again extended its decision on whether the manufacturers of vaping products can market their e-cigarettes in the United States.

Risk Factors Associated with Systemic Sclerosis Hospitalization

A retrospective study of systemic sclerosis patients shows that acute hospitalization and mortality were not uncommon and were often linked to SSc-related lung disease.